1 study found for:    NCT00932893
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Active, not recruiting
Has Results
An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: PF-02341066;   Drug: Pemetrexed;   Drug: Docetaxel

Indicates status has not been verified in more than two years